Merck Funding for Pediatric Vaccine Research

A representative of the Merck Investigator Studies Program (MISP) recently reached out to CHRI/PRO to encourage our investigators to submit proposals for funded projects in the areas of interest listed below. Projects can be up to 2 years in length, with budgets under $1 million considered. Proposal deadlines vary based on research area. 

Please reach out to Ashley Servais, CHRI Senior Research Manager (ashley.servais@unmc.edu), for more information and contact details at Merck.  

HPV: http://engagezone.msd.com/HPV.php

MMR&V: http://engagezone.msd.com/varicella.php

Peds Hexavalent vaccine: http://engagezone.msd.com/PediatricHexavalent.php

Pneumococcus: http://engagezone.msd.com/pneumococcus.php

RSV: http://engagezone.msd.com/RespSynVir.php

Vaccine confidence: http://engagezone.msd.com/Vaccine_Confidence.php

Rotavirus: http://engagezone.msd.com/rotavirus.php

 

posted February 25, 2021